Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2010
05/05/2010CN101700254A Chinese medicine prescription granule flavoring agent, and preparation method and use method thereof
05/05/2010CN101700253A Probiotic tablet and preparation method thereof
05/05/2010CN101700252A Skin-care cream for treating skin cracks
05/05/2010CN101700248A Preparation method of Aspirin and Captopril enteric sustained-release capsule
05/05/2010CN101700244A Novel wound paste constructed by water absorption pad of purely natural material
05/05/2010CN101700243A Novel medicine carrying woundplast with treating function
05/05/2010CN101700241A Raloxifene emplastrum preparation and preparation method thereof
05/05/2010CN101700240A Preparation method of captopril bioadhesive sustained-release capsule
05/05/2010CN101700236A Vitamin c soft capsule
05/05/2010CN101700235A Self-assembling compound film-controlled slow-release preparation and preparation method thereof
05/05/2010CN101700232A Cefprozil submicron emulsion solid preparation and new application thereof
05/05/2010CN101700231A Solid preparation comprising pantoprazole sodium submicron emulsion particles
05/05/2010CN101700230A Monosialote rahexosylganglioside microsphere and preparing method thereof
05/05/2010CN101700229A Prostaglandin E1 long-circulation fat microsphere preparation for intravenous injection and preparation method thereof
05/05/2010CN101700228A Preparation method of amino polysaccharide Aspirin composite nanometer particles
05/05/2010CN101700227A Matrine colon targeted adhesive pellet and preparation method thereof
05/05/2010CN101700226A Naltrexone long-acting sustained-release preparation with no need of coating and preparation method thereof
05/05/2010CN101700225A Fat emulsion injection and production method thereof
05/05/2010CN101700224A Method for preparing oral chondroitin sulfate nanoemulsion
05/05/2010CN101700222A Oridonin solid dispersion preparation
05/05/2010CN101065120B 4-hydroxy tamoxifen gel formulations
05/05/2010CN101044244B Isocyclomaltooligosaccharide, isocyclomaltooligosaccharide synthase, process for producing them and use thereof
05/05/2010CN101023119B Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
05/05/2010CN101001629B Medicinal composition
05/04/2010US7711174 Methods and systems for imaging cells
05/04/2010US7709556 Radiation and radiochemically sterilized absorbable devices with dose-controlled functional strength retention
05/04/2010US7709536 Pharmaceutical formulation
05/04/2010US7709529 Treatment of cancer with glutamine
05/04/2010US7709464 Drud delivery; prolonging the time a pharmaceutical drug circulates in the blood of a subject by using a liposome containing the inventive compound as a carrier
05/04/2010US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter
05/04/2010US7709457 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol
05/04/2010US7709452 Pharmaceutical composition which improves in vivo gene transfer
05/04/2010US7709442 In vivo synthesis of connective tissues
05/04/2010US7709260 Sealing closure of bacterial ghosts by means of bioaffinity interactions
05/04/2010US7709252 Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
05/04/2010US7709028 Particulate product comprising pantethine
05/04/2010US7709026 Synergistic mixture reducing pH, adjustment oxygen concentration containing peroxy compound and bioadhesive
05/04/2010US7709022 Sustained-release preparations of quinolone antibiotics and method for preparation thereof
05/04/2010US7709012 Ophthalmic compositions containing a synergistic combination of two polymers
05/04/2010US7709011 Cosmetic or pharmaceutical preparations comprising an oxalkylated polyglycerol ester
05/04/2010US7708988 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium
05/04/2010US7708978 Water-solubility macromolecule conjugate with interferon; polyoxyethylene glycol, polyoxypropylene glycol or copolymers; one end group having a glucose attached, the other an interferon; long physiological cycle half-life; bioavailability; binds to asialoglycoprotein receptors on liver; hepititis B/C
05/04/2010CA2514158C Enhanced production of clotting factors by cryoprecipitation
05/04/2010CA2476587C Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
05/04/2010CA2463896C Injectable compositions for the controlled delivery of pharmacologically active compound
05/04/2010CA2455566C (+)-cycloolivil as antioxidant obtained from stereospermum personatum
05/04/2010CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition
05/04/2010CA2427385C Nutritional composition for an immune condition
05/04/2010CA2417646C Topical gel delivery system
05/04/2010CA2378438C Methods for preparation of lipid-encapsulated therapeutic agents
05/04/2010CA2375083C Clear oil-containing pharmaceutical compositions
05/04/2010CA2367636C Fusion proteins
05/04/2010CA2352484C Pressurised metered dose inhalers (mdi)
05/04/2010CA2335364C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
05/04/2010CA2319057C Compositions comprising a poly(oxyethylene)-poly(oxypropylene) block copolymer and their use
05/04/2010CA2282439C Formulations for hydrophobic pharmaceutical agents
05/04/2010CA2158134C Supplemented tissue sealant
04/2010
04/29/2010WO2010048087A2 Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
04/29/2010WO2010047799A1 Swellable biodegradable polymeric matrices and methods
04/29/2010WO2010047607A2 Method of production of polyanionic drug-carrier conjugates
04/29/2010WO2010047381A1 Stable tablet containing 4,5-epoxymorphinan derivative
04/29/2010WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract
04/29/2010WO2010046917A2 Fludarabine phosphate composition
04/29/2010WO2010046856A1 A functionalized cyanine having a silane linker arm, a method of preparing thereof and uses thereof
04/29/2010WO2010046628A1 Compounds
04/29/2010WO2010046583A1 Microcapsules having an envelope composed essentially of silsesquioxane homopolymers or copolymers
04/29/2010WO2010046377A2 Immunoactivating conjugates comprising nanoparticles coated with peptides
04/29/2010WO2010046375A1 Urea-based film-forming solution for treating nail psoriasis
04/29/2010WO2010046357A1 Amylin derivatives
04/29/2010WO2010045896A2 Polymeric composition with synergistic effect in treatment of tumour diseases
04/29/2010WO2010045788A1 A orally disintegrating tablet of donepezil hydrochloride and the preparation method thereof
04/29/2010WO2010045700A1 Method for preparing a veterinary suspension formulation for administering water-insoluble medicaments
04/29/2010WO2010045682A1 Storage stable compositions and methods for preparing same
04/29/2010WO2010027405A3 Formulations of gc-c receptor agonist polypeptides
04/29/2010WO2010011609A3 Controlled release antimicrobial compositions and methods for the treatment of otic disorders
04/29/2010WO2009034453A4 Method for the immobilization of bioactive molecules within a polymeric substrate resistant to the stomach acids as oral drug delivery system
04/29/2010WO2009010270A8 Purification of pegylated polypeptides
04/29/2010WO2008012525A8 Derivatisation of granulocyte colony-stimulating factor
04/29/2010US20100105946 Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)
04/29/2010US20100105896 Pharmaceutical compounds
04/29/2010US20100105870 Method Of Complexing A Protein By The Use Of A Dispersed System And Proteins Thereof
04/29/2010US20100105869 Physiologically Active Polypeptide Conjugate Having Prolonged In Vivo Half-Life
04/29/2010US20100105784 Pharmaceutical Pellets Comprising Modified Starch and Therapeutic Applications Therefor
04/29/2010US20100105783 Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same
04/29/2010US20100105781 Abuse resistant lysine amphetamine compounds
04/29/2010US20100105715 Polymer conjugates of opioid antagonists
04/29/2010US20100105672 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
04/29/2010US20100105628 Reducing post-operative adhesion formation with intraperitoneal glutamine
04/29/2010US20100105624 Calcitonin drug-oligomer conjugates, and uses thereof
04/29/2010US20100105606 Methods for making high oxygen affinity modified hemoglobin for oxygen transport
04/29/2010US20100105123 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
04/29/2010US20100105107 Purification and characterization of soluble mhc proteins
04/29/2010US20100104656 Meltable Binder for Melt Granulation and/or Pelletization
04/29/2010US20100104655 Therapeutic Polymeric Nanoparticles Comprising Vinca Alkaloids and Methods of Making and Using Same
04/29/2010US20100104650 Charged mesoporous silica nanoparticle-based drug delivery system for controlled release and enhanced bioavailability
04/29/2010US20100104647 Hollow microparticles
04/29/2010US20100104629 Cationic lipids and uses thereof
04/29/2010US20100104619 Delivery system for a non-steroidal non-ionized hydrophilic drug
04/29/2010US20100104617 Graft prosthesis, materials and methods
04/29/2010US20100104588 Serum albumin binding peptides for tumor targeting
1 ... 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 ... 1712